Previous Meetings

GBCC 2011

Global Breast Cancer Conference 2011

09:00-09:40
Plenary I
Venue: Vista I+II
  • The Challenge of Breast Cancer
    Eric P. Winer (Breast Oncology Center, Dana-Farber Cancer Institute, U.S.A.)
10:20-11:20
Symposium I
Breast Cancer Screening in Asia: Should It Be Different from Strategies of Western Country?
Venue: Vista I+II+Ⅲ
  • Breast Cancer Screening in Korea
    Hak Hee Kim (Department of Radiology, ASAN Medical Center, Korea)
  • Breast Cancer Screening in Japan
    Shoshu Mitsuyama (Department of General Surgery, Kitakyushu Municipal Medical Center, Japan)
Symposium II
Risk, Epidemiology, and Prevention of Breast Cancer
Venue: MGB I+II
  • Breast Cancer Prevention
    Jennifer Eng-Wong (Department of Internal Medicine, Lombardi Cancer Center, U.S.A.)
  • Determining Factors of Breast Cancer Survival in Seoul Breast Cancer Study
    Daehee Kang (Department of Preventive Medicine, Molecular and Genomic Epidemiology Laboratory, College of Medicine, Seoul National Univ., Korea)
11:20-12:40
Symposium III
Breast Cancer with Luminal Subtypes
Venue: Vista I+II+Ⅲ
  • Individualization for Therapeutic Management of Luminal Subtype Breast Cancer
    Shin-ichi Hayashi (Molecular and Functional Dynamics, Graduate School of Medicine, Tohoku Univ., Japan)
  • Pathologic and Clinical Aspects of Luminal Subtype Breast Cancer
    Gyungyub Gong (Department of Pathology, ASAN Medical Center, Korea)
  • Estrogenreceptor Status Predictionby Gene Component Regression: A Comparative Study
    Chi-Cheng Huang (Medical Education and Research, Cathay General Hospital SiJhih, Taiwan)
Symposium IV
Axillary Surgery in Patients with Breast Cancer
Venue: MGB I+II
  • Preoperative Axillary Staging
    Sehwan Han (Department of General Surgery, Inje Univ. Sanggye Paik Hospital, Korea)
  • Recent Advance and Controversial Issus in Sentinel Node Biopsy
    Ming-feng Hou (Cancer Center, Kaohsiung Medical Univ. Chung-Ho Memorial Hospital, Taiwan)
  • Predictors of Lymph Node Metastase in Breast Cancer
    Chenghar Yip (Department of Surgery, Univ. Malaya Medical Centre, Malaysia)
13:50-15:10
Symposium V
Breast Cancer with HER2 Subtype
Venue: Vista I+II
  • HER2 Positive Breast Cancer: Trastuzumab and Current Treatment Strategies
    Junsil Ro (Breast Cancer Center, National Cancer Center, Korea)
  • HER2-directed Therapy/Development of T-DM1
    Ian Krop (Department of Medical Oncology, Dana-Farber Cancer Institute, U.S.A.)
  • HER2 Pathway Biology Focusing on p95
    Joaquin Arribas (Basic Research, Vall d’Hebron Institute of Oncology (VHIO), Spain)
Symposium VI
Controversies in Radiation Therapy
Venue: MGB I
  • Current Status of Accelerated Partial Breast Irradiation (PBI)
    Sung-Ja Ahn (Department of Radiation Oncology, Chonnam National Univ. Hwasun Hospital, Korea)
  • Radiotherapy for DCIS
    Jin Hee Kim (Department of Radiation Oncology, Keimyung Univ. Dongsan Medical Center, Korea)
  • Accelerated Whole Breast Irradiation (AWBI) in Breast Cancer
    Kyung Hwan Shin (Proton Therapy Center/Radiation Oncology, National Cancer Center, Korea)
Symposium VII
Helping Health Professionals Acquire Communication Skills
Venue: MGB II
  • Effective Communication across the Cancer Trajectory: What Patients Can Teach Us
    Sally Thorne (School of Nursing, Univ. of British Columbia, Canada)
  • Effective Communication in Oncology ANP of Japan
    Kazuko Onishi (Faculty of Medicine, School of Nursing, Mie Univ., Japan)
  • Communication between Health Care Provider and Patients
    Jong-min Woo (Department of Neuropsychiatry, Inje Univ. Seoul Paik Hospital, Korea)
  • Conversation Analysis to Improve Oncology Nursing Communication
    Myungsun Yi (College of Nursing, Seoul National Univ., Korea)
15:30-16:30
Free Paper I
Risk & Prevention, Others
Venue: Vista Ⅲ
  • THE RISK OF BREAST CANCER ASSOCIATED WITH SPECIFIC MUTATION OF BRCA1 AND BRCA2 AMONG KOREAN POPULATION
    Boyoung Park (National Cancer Control Institute, National Cancer Center, Korea)
  • METFORMIN INHIBITS THE GROWTH OF HUMAN BREAST CARCINOMA (MCF-7) MAMMOSPHERE CELLS PROMOTED BY ESTROGEN, TCDD, AND BIS-PHENOL A
    James Trosko (Department of Pediatrics and Human Development, Michigan State Univ., U.S.A.)
  • PREDICTIVE FACTOR OF UNDERESTIMATION OF ULTRASOUND-GUIDED CORE NEEDLE BIOPOSY (cnb)
    Jisun Kim (Department of Breast Endocrine Surgery, Seoul National Univ. Hospital, Korea)
Free Paper II
Detection and Diagnosis
Venue: MGB I
  • CLINICOPATHOLOGIC CHARACTERISTICS OF BREAST CANCERS DETECTED BY ULTRASOUND
    Min Sun Bae (Department of Radiology, Seoul National Univ. Hospital, Korea)
  • LYMPHOVASCULAR INVASION AND TUMOR SIZE ARE PREDICTORS OF SENTINEL LYMPH NODE INVOLVEMENT IN CLINICALLY NODE NEGATIVE BREAST CANCER PATIENT
    Mohamed Al-bashir (Department of General Surgery, Tawam Hospital, U.A.E.)
  • EVALUATION OF TUMOR SIZE IN BREAST CANCER PATIENTS USING MRI NAVIGATED ULTRASOUND (US)
    Jung Min Chang (Department of Radiology, Seoul National Univ. Hospital, Korea)
  • BILATERAL PREOPERATIVE MR EXAMINATIONS IN NEWLY DIAGNOSED BREAST CANCER PATIENTS: INITIAL AND LONG-TERM IMPACT ON CONTRALATERAL BREAST CANCER DIAGNOSIS
    Jin-you Kim (Department of Radiology, Seoul National Univ. Hospital, Korea)
  • MULTIPLE MARGIN POSITIVITY IN FROZEN SECTION AS A TRIGGER FACTOR TO LOCAL FAILURE OF BREAST CANCER SURGERY
    Jee Yeon Lee (Department of General Surgery, Breast Clinic, Pusan National Univ. Hospital, Korea)
Free Paper III
Treatment
Venue: MGB Ⅱ
  • MANAGEMENT OF EARLY BREAST CANCER: PATTERNS OF PRACTICE IN PAKISTAN
    Hasan Bin Hamza (Discipline of Public Health, Univ. of Adelaide, Australia)
  • C-MET EXPRESSION AND MOLECULAR TARGETING THERAPY IN TRIPLE-NEGATIVE BREAST CANCER
    Shinichiro Kashiwagi (Department of Surgical Oncology, Graduate School of Medicine, Osaka City Univ., Japan)
  • YOUNG AGE IS ASSOCIATED WITH IPSILATERAL BREAST TUMOR RECURRENCE AFTER BREAST CONSERVING SURGERY AND RADIATION THERAPY IN HER2-POSITIVE/ER-NEGATIVE SUBTYPE
    Hee jeong Kim (Department of Breast Surgery, ASAN Medical Center, Korea)
  • THE NUMBER OF SENTINEL LYMPH NODES REMOVED AND QUALITY OF LIFE AMONG EARLY BREAST CANCER PATIENTS DURING ACTIVE TREATMENT
    Im-ryung Kim (Cancer Education Center, Samsung Comprehensive Cancer Center, Samsung Medical Center, Korea)
  • CHINA MULTICENTER STUDY OF SENTINEL NODE BIOPSY SUBSTITUTING AXILLARY NODE DISSECTION: CBCSG-001 TRIAL WITH 5 YEARS FOLLOW-UP
    Yong-Sheng Wang (Breast Cancer Center, Shandong Cancer Hospital & Institute, China)
  • EFFECT OF THE MIXED SOLUTION OF SODIUM HYALURONATE AND SODIUM CARBOXYMETHYLCELLULOSE ON UPPER LIMB DYSFUNCTION AFTER TOTAL MASTECTOMY: A RANDOMIZED DOUBLE-BLIND CLINICAL TRIAL
    Eun Joo Yang (Department of Rehabilitation, Seoul National Univ. Bundang Hospital, Korea)
Free Paper IV
Oncology Nursing
Venue: Cosmos
  • DEVELOPMENT OF NAVIGATION PROGRAM FOR NEWLY DIAGNOSED PATIENTS WITH BREAST CANCER IN KOREA
    Hye Jin Baek (Breast Cancer Center, Samsung Medical Center, Korea)
  • THE EFFICACY OF BREAST CANCER EDUCATION FOR JAPANESE YOUNG FEMALES
    Tousei Ohmura (Department of General Surgery, Sapporo Medical Univ. Hospital, Japan)
  • EFFECTS OF COMBINED AEROBIC AND RESISTANCE EXERCISE PROGRAM ON QUALITY OF LIFE BREAST CANCER SURVIVORS IN IRAN
    Fariba Taleghani (School of Nursing and Midwifery, Isfahan Univ. of Medical Science, Iran)
  • BONE LOSS IN BREAST CANCER SURVIVORS: PREVALENCE, RISK FACTORS, AND ASSOCIATION WITH QUALITY OF LIFE
    Soo Hyun Kim (Department of Nursing, Inha Univ., Korea)
  • OVARIAN FUNCTION AND MENOPAUSE-SPECIFIC QUALITY OF LIFE IN PREMENOPAUSAL WOMEN RECEIVING ADJUVANT CHEMOTHERAPY FOR BREAST CANCER
    Mira Yun (Outpatient Nursing Team, ASAN Medical Center, Korea)
16:40-18:00
Symposium VIII
Breast Cancer with Triple Negative Subtype
Venue: MGB I
  • Triple Negative Breast Cancer: Pathologic and Molecular Features
    Young Kyung Bae (Department of Pathology, Yeungnam Univ. Medical Center, Korea)
  • New Strategies for Treatment of Triple Negative Breast Cancer
    Jin-Hee Ahn (Department of Oncology, ASAN Medical Center, Korea)
  • PPAR Gamma Regulates Tumor-specific Repression of MNSOD Expression
    Alan Prem Kumar (Cancer Science Institute of Singapore, National Univ. of Singapore, Singapore)
Symposium IX
Individualized Treatment for Patients with Loco-regional Recurrence and Metastatic Disease
Venue: MGB II
  • Individualized Overall Treatment Programs for Patients with Loco-regional Recurrence
    Jeong Eon Lee (Division of Breast, Department of General Surgery, Samsung Medical Center, Korea)
  • Management for Ipsilateral Breast Recurrence after Breast Conservation Treatment
    Tadashi Ikeda (Department of General Surgery, School of Medicine, Teikyo Univ., Japan)
  • Systemic Treatment Strategies in Metastatic Disease
    Cosphiadi Irawan (Division Hematology-medical Oncology, Dr. Cipto Mangunkusumo General Hospital, Indonesia)
Symposium X
Evidence Based Practice to Improve Cancer Care
Venue: Cosmos
  • Building Evidence in Oncology Nursing Care
    Eunyoung Eunice Suh (College of Nursing, Seoul National Univ., Korea)
  • Menopausal Symptom Management in Patients with Breast Cancer
    Janet S. Carpenter (Department of Adult Health, School of Nursing, Indiana Univ., U.S.A.)
  • Evidence-based Oncology Nursing Practice in Korea
    In Gak Kwon (Department of Nursing, Samsung Medical Center, Korea)
Back to Previous Meetings